Which statement about the action of tricyclic antidepressants is true?

Which statement about the action of tricyclic antidepressants is true?

• A. Norepinephrine and Serotonin Reuptake Inhibition
• B. GABA Enhancement
• C. Dopamine Receptor Blockade
• D. Acetylcholine Release Inhibition

Answer: (A)

The key idea is that tricyclic antidepressants primarily raise mood by blocking the reuptake of two monoamines—norepinephrine and serotonin—in the presynaptic neuron. By inhibiting the transporters for these chemicals (NET and SERT), more of them stay in the synapse to stimulate their receptors, which helps improve depressive symptoms. This dual reuptake inhibition is the main reason TCAs are effective as antidepressants. Other effects you might notice with TCAs—such as anticholinergic, antihistaminic, and alpha-adrenergic blockade—come from their broader receptor interactions, which also explain common side effects like dry mouth, blurred vision, drowsiness, and orthostatic hypotension. But those actions are separate from the primary mechanism that boosts mood. The options mentioning enhancement of GABA transmission, dopamine receptor blockade, or inhibition of acetylcholine release don’t describe how TCAs work to relieve depression. GABA and dopamine pathways aren’t the main targets of TCAs, and their antidepressant effect isn’t about reducing acetylcholine release.

The key idea is that tricyclic antidepressants primarily raise mood by blocking the reuptake of two monoamines—norepinephrine and serotonin—in the presynaptic neuron. By inhibiting the transporters for these chemicals (NET and SERT), more of them stay in the synapse to stimulate their receptors, which helps improve depressive symptoms. This dual reuptake inhibition is the main reason TCAs are effective as antidepressants.

Other effects you might notice with TCAs—such as anticholinergic, antihistaminic, and alpha-adrenergic blockade—come from their broader receptor interactions, which also explain common side effects like dry mouth, blurred vision, drowsiness, and orthostatic hypotension. But those actions are separate from the primary mechanism that boosts mood.

The options mentioning enhancement of GABA transmission, dopamine receptor blockade, or inhibition of acetylcholine release don’t describe how TCAs work to relieve depression. GABA and dopamine pathways aren’t the main targets of TCAs, and their antidepressant effect isn’t about reducing acetylcholine release.